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Abstract
Background
Onyx liquid embolic system has been used in the treatment of intracranial aneurysm and arteriovenous malformation since 1999. Recently, Onyx HD-500 has been especially advocated for the
treatment of large and giant intracranial aneurysms.
Methods
Two cases of cranial nerve palsy following embolization of unruptured symptomatic giant cavernous
internal carotid artery aneurysms are presented. The first patient had a right 2.0cm x 1.5cm cavernous
aneurysm, and the second a 2.7cm x 1.8cm left cavernous aneurysm. Both patients developed
persistent diplopia after embolization with Onyx HD-500.
Results
Ophthalmological evaluation revealed that both patients had abductor nerve palsy on the same side
as the aneurysm; in addition the second patient also had ipsilateral occulomotor nerve palsy.
Conclusion
Embolization of giant cavernous aneurysm with Onyx HD-500 can result in worsening or development
of new cranial nerve palsies; possibly from mass effect resulting from edema and thrombosis of the
aneurysm in the cavernous sinus.
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Introduction
Onyx HD-500 is a biocompatible non-adhesive liquid embolic agent composed of 20% ethylene- vinyl
alcohol (EVOH) copolymer and dimethyl sulfoxide (DMSO) solvent added to micronized tantalum
powder, a high- molecular- weight metal that renders the solution radiopaque3. Onyx HD-500 differs
from other liquid embolic systems in that it has the highest polymer concentration at 20%, versus 12%
in the original formulation for aneurysm treatment. Higher polymer concentration results in higher
viscosity thus lowering the chance of reflux in parent vessels.

Case Report
Case 1
A 60-year-old female initially presented to her primary care physician with complains of fatigue and
left hemibody numbness. Her evaluation included magnetic resonance imaging of the brain, which led
to the incidental diagnosis of a 1.5cm right cavernous ICA aneurysm. The patient was subsequently
lost to follow-up and presented again 5 years later when she started noticing episodes of blurry vision.
At this time, neurological and ophthalmological evaluation did not reveal any permanent deficit. All
cranial nerves were intact, visual fields were full, and visual acuity was 20/30 in both eyes. A repeat
MR angiogram revealed that the aneurysm increased in size to 1.8cm. After a discussion of the risks
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and benefit of surgery, the patient opted for
endovascular intervention. She underwent
balloon-assisted glue embolization of the aneurysm. Complete obliteration of the aneurysm
was achieved with 4.8 mL of Onyx HD-500.
There were no intra-operative complications.
However, the patient developed diplopia
secondary to partial abducens nerve palsy postoperatively. The patient was treated with a fast
steroid taper. At her 3 months follow-up, she
was noted to have persistence of the partial right
abducens nerve palsy.
Case 2
A 58-year-old male with progressive memory
difficulty was evaluated with MR imaging of the
brain by his primary care physician. This workup led to the incidental diagnosis of a 1.3cm left
cavernous-ICA aneurysm. At the time, patient
denied any headache or vision changes. After discussion of management options, the patient and
family decided to have the aneurysm followedup. Over the next three years, the aneurysm
remained stable on serial MRA. However, on
subsequent follow-up, patient reported an acute
persistent diplopia which was more pronounced
with left gaze. On examination, the patient was
found to have partial left abducens nerve palsy;
his neurological and ophthalmological exams
were otherwise normal. This instance, an MRA
revealed a significant increase in the size of the
left cavernous-ICA aneurysm to 2.7 cm. After
discussion of the risks and benefit of surgery, the
patient underwent balloon-assisted glue embolization of the aneurysm. Complete obliteration
was achieved with 8.4mL of Onyx HD-500 (see
Figure 1); there were no intra-operative complications. Post-operatively, the patient developed worsening of his diplopia. Neurological
exam revealed complete left abducens nerve
palsy and partial left occulomotor nerve palsy.
After a short course of steroid, the patient had
resolution of the left occulomotor nerve palsy.
However, he had persistence of the left abducens
palsy through his last visit with us for a six-week
follow-up.
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Figure 1
(A, B) AP/Lateral views of a 2.7cm left cavernous carotid aneurysm; (C, D) AP/Lateral views Onyx HD-500 injection; (E, F) AP/Lateral views post
embolization with 100% occlusion.

Discussion
The primary goal of intracranial un-ruptured
aneurysm treatment is complete occlusion
to avoid the potentially high morbidity and
mortality associated with acute rupture. Several
studies have shown that incomplete occlusion
following open surgical and endovascular
treatment of aneurysms is associated with rebleeding.6,7,13 Since their introduction in the
1990s, GDC coils have grown in popularity
are now accepted as a reasonable endovascular
treatment modality for intracranial aneurysms.
Nevertheless, initial studies showed that
endovascular coiling with regular platinum
coils had a higher rate of incomplete occlusion
and recanalization when used for wide neck
aneurysms (with a neck larger than 4mm and
a dome to neck ratio less than 1.5) as well as
for large and giant aneurysms.4,5,8 Since then,

newer technologies have been developed to
improve thrombosis of the dome and neck
of the aneurysm, while preserving the parent
vessels integrity. These technologies include
stent-assisted coiling, balloon assisted coiling
and embolization with a liquid embolic agent
such as Onyx HD-500.
Onyx HD-500 is thought to be particularly
applicable to the treatment of wide neck and
large aneurysms; it has been shown to have a
higher rate of complete occlusion.10,12 Since
it is a liquid material, it can be made to fill
close to 100% of the aneurysm capacity; the
use of balloon assistance technique allows
for modeling of the cast to preserve the
parent vessel. In addition, because of its high
viscosity, Onyx HD-500 has a lower chance
of refluxing into the parent vessel and causing
thrombo-embolic events. Another important

characteristic of Onyx HD-500 is its ability to
induce a stronger neo-epithelialization reaction
at the neck of the aneurysm.9,10
Few studies have reported complications from
mass effect of the liquid embolic agents on adjacent structures. They mainly described cranial
nerve palsies,2,10,12 and in rare instances, motor
deficits from compression of critical intracranial structures.11 Cranial nerves commonly
involved are the optic nerve with supraclinoidalICA aneurysms; the occulomotor and abducens
nerves for cavernous-ICA aneurysms. In their
series, Weber et al12 presented six cases of
cavernous-ICA aneurysms treated with Onyx
HD-500. One patient had persistence of his cranial nerve palsy; two patients had improvement
overtime, and two had complete resolution.
One patient was asymptomatic. Piske et al10
series included six cavernous-ICA aneurysms
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as well. Three patients had improvement in
their cranial nerve palsy at six month, versus
three with no improvement. The results of our
series corroborate previous reports. One of our
patients had no change in her cranial palsy, and
the other had some improvement in the subacute phase, with chances of further recovery.
We would argue that the combination of high
volume in addition to high density of liquid
embolic material required for the complete
obliteration of large to giant aneurysms might
result in significant mass effect. Such is the case
particularly for cavernous-ICA aneurysm. As
previously speculated by some authors,1,10 we
put forward that the use of a combination of
special coil plus liquid embolic material might
have better outcome for the treatment of such
aneurysms.

Conclusion

Onyx HD-500 is a liquid embolic agent with
high viscosity reducing the chance of reflux
of embolic material into the parent vessel.
This property makes it a reasonable option
for embolization of larger and wider neck
aneurysms. However, in the specific instance
of large and giant cavernous-ICA aneurysms,
the combination of high volume and high
density might result in mass effect and cranial
nerve deficits. For such aneurysms, consideration might be given for combined coiling and
liquid embolization.
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